
About Tanishka Pharmaceuticals Private Limited
Data last updated:
Tanishka Pharmaceuticals Private Limited is a private limited company based in Solan, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 February 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U02423HP2005PTC000895. Its GSTIN is 02AACCT4269K1Z9 (Himachal Pradesh).
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.42 Cr. It was formerly known as Briskon Laboratories Private Limited. It is led by directors including Jaswinder Singh and Rohtas Sharma.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Solan, Himachal Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹12.13 Cr, a decline of 14% compared to the previous year. For the same year it recorded a net profit of ₹7.56 Lakh (net margin 0.6%) and EBITDA of ₹97.95 Lakh (EBITDA margin 8.1%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 11% over five years.
The company has about 48 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹9.92 Cr and satisfied charges of ₹2.54 Cr on record. Court records list 9 cases involving the company, including 1 filed by the company and 8 filed against it; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website tanishkapharmaceuticals.com.
Company details
CIN history
Tanishka Pharmaceuticals has one previous CIN (Corporate Identification Number): U02423MP2005PTC017334. The current CIN is U02423HP2005PTC000895, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U02423HP2005PTC000895 | Current |
| U02423MP2005PTC017334 | Previous |
Contact details
Tanishka Pharmaceuticals Private Limited's registered office is in Solan, Himachal Pradesh. Its website is tanishkapharmaceuticals.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressVillage Nandpur Kharuni – Lodhi Majra Road Post Office Lodhi Majra Tehsil Nalagra, H, Solan, Himachal Pradesh, India – 174101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Tanishka Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Tanishka Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Tanishka Pharmaceuticals Private Limited, buy the company report.
Financials of Tanishka Pharmaceuticals Private Limited
FY 2024 filings availableTanishka Pharmaceuticals Private Limited reported revenue of ₹12.13 Cr (down 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 11% over five years, including a 14% fall in the latest year. EBITDA rose 117% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹97.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.56 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.1% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tanishka Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tanishka Pharmaceuticals Private Limited
Tanishka Pharmaceuticals has 4 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rohtas Sharma | Additional Director | 12 Dec 2017 | 8 Years 11 Months | Current |
| Jaswinder Singh Also directs: Zeylanica Pharmaceuticals Private Limited | Director | 17 Apr 2023 | 3 Years 6 Months | Current |
| Davinder Pal Singh Also directs: Angiolife Healthcare Private Limited | Additional Director | 12 Dec 2017 | 8 Years 11 Months | Current |
| Pankaj Kumar Also directs: Zenacts Pharma Private Limited | Additional Director | 12 Dec 2017 | 8 Years 11 Months | Current |
Peer comparison
Tanishka Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aavkar Drugs Private Limited | ₹12.23 Cr (FY 2023) | -16.0% | Ankleshwar, Gujarat, India | |||
| Maximaa Systems Limited | ₹12.2 Cr (FY 2019) | -2.0% | Valsad, Gujarat, India | |||
| Francis Remedies (India) Private Limited | ₹12.19 Cr (FY 2024) | 38.0% | Delhi, India | |||
| Mac Organics Pvt.Ltd. | ₹12.15 Cr (FY 2023) | 2.0% | Panvel, Maharashtra, India | |||
| Tanishka Pharmaceuticals Private Limitedthis company | ₹12.13 Cr (FY 2025) | ₹7.56 Lakh | 0.6% | -14.0% | 48 | Solan, Himachal Pradesh, India |
| Religrace Parentral India Private Limited | ₹12.11 Cr (FY 2025) | 0.0% | Dewas, Madhya Pradesh, India | |||
| Kayvee Aero Pharm Pvt Ltd | ₹12.1 Cr (FY 2025) | 77.0% | Kadi, Gujarat, India | |||
| Alithia Pharmaceuticals Private Limited | ₹12.08 Cr (FY 2025) | 292.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Tanishka Pharmaceuticals Private Limited, buy the company report.
Auditor
Tanishka Pharmaceuticals Private Limited is audited by ASHWANI & ASSOCIATES CHARTEREDACCOUNTANTS for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ASHWANI & ASSOCIATES CHARTEREDACCOUNTANTS | FY 2023 | 000497N |
Shareholding
The shareholding of Tanishka Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tanishka Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jul 2025 | 101119089 | Canara Bank | ₹6 Cr | Open | |
| 27 Feb 2024 | 100907123 | Hdfc Bank Limited | ₹18.07 Lakh | Open | |
| 25 Mar 2021 | 100446002 | Others | ₹3.5 Cr | Open | |
| 25 Mar 2021 | 100446003 | Others | ₹23.8 Lakh | Open | |
| 30 Oct 2018 | 100232782 | Others | ₹1.69 Cr | Satisfied |
To see the full charge records of Tanishka Pharmaceuticals Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
Tanishka Pharmaceuticals Private Limited has 9 court cases on record: 1 filed by Tanishka Pharmaceuticals, 8 filed against it. 3 cases are pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 5 | 2 |
| District courts | 3 | 3 | 1 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Ajanta Pharma Ltd. | Pending |
| High Court, TAMIL NADU | Court case (C.S(COMM DIV)) | Filed against the company by Sun Pharmaceutical Industries Limited | Disposed |
| Bombay High Court | Court case (S) | Filed against the company by Ajanta Pharma Ltd. | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Ajanta Pharma Ltd. | Disposed |
| District court, DAVANGERE, Karnataka | Criminal complaint | Filed against the company by an individual | Pending |
To see the full case history of Tanishka Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tanishka Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Tanishka Pharmaceuticals Private Limited has a workforce of 48 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 48 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 |
To see the full employee and EPFO history of Tanishka Pharmaceuticals Private Limited, buy the company report.
GST
Tanishka Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AACCT4269K1Z9 | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Tanishka Pharmaceuticals Private Limited, buy the company report.
Recent activity
Tanishka Pharmaceuticals Private Limited has 11 board changes on record since 2015: 4 appointments and 7 cessations. The latest: Jaswinder Singh ceased to be Additional Director on 29 Sep 2023.
13 earlier events are in the company report.
Frequently asked questions
Tanishka Pharmaceuticals is an active private limited company based in Solan, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 February 2005 (21+ years old) and is registered under CIN U02423HP2005PTC000895.
Tanishka Pharmaceuticals has 4 current directors:
- Rohtas Sharma - Additional Director
- Jaswinder Singh - Director
- Davinder Pal Singh - Additional Director
- Pankaj Kumar - Additional Director
The latest financial statements of Tanishka Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Tanishka Pharmaceuticals is 02AACCT4269K1Z9, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Tanishka Pharmaceuticals is U02423HP2005PTC000895. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tanishka Pharmaceuticals has 9 court cases on record: 1 filed by the company and 8 filed against it. 3 are pending. Most are in the high courts.
Tanishka Pharmaceuticals was incorporated on 11 February 2005, making it 21+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Tanishka Pharmaceuticals by revenue are Aavkar Drugs Private Limited, Maximaa Systems Limited, Francis Remedies (India) Private Limited, Mac Organics Pvt.Ltd, Religrace Parentral India Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jaswinder Singh ceased to be Additional Director on 29 Sep 2023. Jaswinder Singh was appointed as Director on 17 Apr 2023. Gulshan Rawat ceased to be Additional Director on 14 Apr 2023. Tanishka Pharmaceuticals has 11 board changes on record in total.
Tanishka Pharmaceuticals can be reached through the website tanishkapharmaceuticals.com. Its registered office is in Solan, Himachal Pradesh, India.
The registered office of Tanishka Pharmaceuticals is at Village Nandpur Kharuni – Lodhi Majra Road Post Office Lodhi Majra Tehsil Nalagra, H, Solan, Himachal Pradesh, India – 174101.

